rare diagnostics
Verified IntelGenome.One is a pioneering health information company providing genetic answers to life's biggest health questions through clinically-accredited genome sequencing and analysis. We aim to enhance the lives of patients, families and communities across the world by enabling the future of precision healthcare. Genome.One is a wholly owned subsidiary of the Garvan Institute of Medical Research. OUR MISSION Transforming lives through genomics. OUR VISION By 2025, Genome.One technology and services will empower healthcare and lifestyle decision-making using genomic information - for millions of people, in Australia and across the world.
Genome.One is a pioneering health information company providing genetic answers to life's biggest health questions through clinically-accredited genome sequencing and analysis. We aim to enhance the lives of patients, families and communities across the world by enabling the future of precision healthcare. Genome.One is a wholly owned subsidiary of the Garvan Institute of Medical Research. OUR MISSION Transforming lives through genomics. OUR VISION By 2025, Genome.One technology and services will empower healthcare and lifestyle decision-making using genomic information - for millions of people, in Australia and across the world.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 51-200
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 370 Victoria St NSW Darlinghurst
- City
- Darlinghurst
- Region / State
- New South Wales
- Postal Code
- 2010
- Country
- Australia
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for rare diagnostics.